Recommended from Around the Web (Week ending October 17, 2015)
Hot Startup Theranos Has Struggled with Its Blood-Test Technology
An investigative report by the Wall Street Journal questioning Theranos’s technology.
—Antonio Regalado, senior editor, biomedicine
Four Reasons Drugs Are Expensive, of Which Two Are False
Forbes explores why drugs are so expensive.
—Antonio Regalado
Alzheimer’s Research Effort Is Ensnared in Legal Dispute
What happens when one university lifts a research team from another.
—Antonio Regalado
Raiders of the Lost Web
Coming to grips with how much stuff vanishes from the Web.
—Brian Bergstein, executive editor
The Soul of the Human Machine
A commonsense way of thinking about the future of AI.
—Brian Bergstein
If You’re Not Paranoid, You’re Crazy
The cover story in this month’s Atlantic gets all twitchy about the extent to which we let ourselves be tracked and quantified nowadays.
—Will Knight, senior editor, AI
Doppelgänger
An amusing and oddly revealing meeting between Apple cofounder Steve (“Woz”) Wozniak and Seth Rogen, who plays him in a new film.
—Will Knight
Keep Reading
Most Popular

Why China is still obsessed with disinfecting everything
Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.

These materials were meant to revolutionize the solar industry. Why hasn’t it happened?
Perovskites are promising, but real-world conditions have held them back.

Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.

A quick guide to the most important AI law you’ve never heard of
The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.
Stay connected

Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.